- Intercept Pharma ( NASDAQ: ICPT ) is scheduled to announce Q4 earnings results on Thursday, March 2nd, before market open.
- The consensus EPS Estimate is -$0.46 (+62.6% Y/Y) and the consensus Revenue Estimate is $78.08M (-15.5% Y/Y).
- Over the last 1 year, ICPT has beaten EPS estimates 75% of the time and has beaten revenue estimates 100% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 3 downward. Revenue estimates have seen 1 upward revision and 9 downward.
For further details see:
Intercept Pharma Q4 2022 Earnings Preview